𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia

✍ Scribed by Real, P J; Ferrando, A A

Book ID
109887108
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
93 KB
Volume
23
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

T-cell acute lymphoblastic leukemia foll
T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma
✍ Kaplinsky, Chaim ;Frisch, Amos ;Cohen, Ian J. ;Goshen, Yacov ;Jaber, Lutfi ;Yani πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 420 KB

## Abstract Multiple studies have documented an increased risk of secondary malignancies in patients receiving alkylating agents. Secondary leukemia following chemotherapy accounts for about 20% of all secondary neoplasms; most are acute nonlymphocytic. Secondary acute lymphoblastic leukemia has ra

Mediastinal mass in childhood T-cell acu
Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: Significance and therapy response
✍ Attarbaschi, Andishe ;Mann, Georg ;Dworzak, Michael ;Wiesbauer, Peter ;Schrappe, πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 156 KB

## Abstract ## Background T‐cell acute lymphoblastic leukemia (T‐ALL) accounts for ∼10–13% of childhood ALL cases. Patients with T‐ALL frequently present with unfavorable features at diagnosis and thus are considered to have a higher risk to relapse. Within the last 10 years, the previously dismal